-
Pharmaceutical ETF shares increased this month, boosting market confidence
Time of Update: 2023-01-05
In the case of an increase in the share of ETFs in the pharmaceutical industry, to a certain extent, it can be seen that funds are optimistic about the pharmaceutical sector, which will help boost market confidence.
-
University of York's weight loss research shows that if you don't succeed in the beginning, try again
Time of Update: 2022-09-30
It's all too common for those trying to lose weight to bounce back as soon as they finish their diet (often described as an individual's failure, indicating a lack of willpower and self-discipline), but a new study by academics at the University of York's School of Health found that this regression is a learning experience — and may even be a necessary step toward sustained weight loss and improved overall health.
-
National Medical Insurance Administration: Timely adjustment of new crown treatment drugs included in the scope of medical insurance payment
Time of Update: 2022-04-24
The notice pointed out that for the newly added drugs in the "Diagnosis and Treatment Plan (Trial Version 9)", all provincial medical security departments should refer to the "Notice of the National Medical Security Administration and the Ministry of Finance on Doing a Good Job in Medical Insurance for Pneumonia Infected by Novel Coronavirus" (National Medical Insurance (2020) No.
-
Long-term follow-up results of phase II study of cladribine combined with rituximab in the treatment of variant hairy cell leukemia announced
Time of Update: 2022-03-09
Among the 17 patients who achieved blood MRD negativity after CDAR treatment, the median survival was 70.
There are currently 7 patients with negative blood MRD for a duration of 27-139 months (median 59.
-
Shanxi fully implements the centralized procurement of 71 kinds of drugs, the selected results reduce the burden of drugs
Time of Update: 2021-11-04
China News Service, Taiyuan, October 18 (Wu Qiong) The reporter learned from the Shanxi Provincial Medical Insurance Bureau on the 18th that from October 20th, all public medical institutions in Shanxi Province will fully implement the national fifth batch of 61 drugs and the "eight provinces and two The result of the selection of 10 kinds of medicines in the district alliance allows patients to enjoy the effect of price reduction of medicines purchased in quantity .
-
The second session of the digestive tract tumor MDT launch will be held in Hara
Time of Update: 2020-08-13
"multidisciplinary comprehensive treatment (MDT), in short, 'three solids'," said Professor Zhang Yanqiao, vice president of Harbin Medical University Affiliated Oncology Hospital, MDT is a relatively fixed group of experts from more than two disciplines who come together at a fixed time and place to discuss and form a resolution on diagnosis and treatment for patients with an organ or systemic disease.
-
How do pharmaceutical companies adapt to health insurance fees? The national supplies code is coming
Time of Update: 2020-07-09
(2020/06/05) people to middle-aged pharmaceutical companies sales were cut to cry local version of the volume of procurement than the national version of the list of research and development costs: 47
-
MIB index predicts the value of the recurrence of the diffuse vestibular neuroblastoma
Time of Update: 2020-06-03
The literature reports that the MIB-1 marker index (LI) plays an important role in the recurrence of pretrial neurosyma Pretrial neuroblastomas, which express the apoptosis factor Bax, showed a higher
-
In the era of "post generic drugs", pharmaceutical companies are holding group heating through the strategy of M
Time of Update: 2019-08-22
[industry trends of pharmaceutical network] now it is in the era of "post generics" The problem of overproduction of generics is prominent The growth rate of net profit of many pharmaceutical companie
